TrialAmerican heart journal2019

Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.

Heerajnarain Bulluck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.